The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEden Regulatory News (EDEN)

Share Price Information for Eden (EDEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.275
Bid: 4.15
Ask: 4.40
Change: -0.025 (-0.58%)
Spread: 0.25 (6.024%)
Open: 4.30
High: 4.325
Low: 4.275
Prev. Close: 4.30
EDEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Eden and Corteva seek to bring Ecovelex to market

30 May 2023 07:00

RNS Number : 8840A
Eden Research plc
30 May 2023
 

As the information in this release pertains to EDEN RESEARCH PLC, this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

 

Eden Research plc and Corteva Agriscience Seek to Bring Ecovelex™ to EU and UK Market

 

The seed treatment product helps farmers safely repel birds

 

 

GENEVA, Switzerland, 30 May, 2023 - Eden Research plc has applied for the authorization of Ecovelex™ in the EU, with application in the UK to follow, with Corteva Agriscience as its distribution partner. Eden is an AIM listed company that develops and supplies sustainable solutions for crop protection, animal health and consumer products.

 

Developed by Corteva Agriscience and Eden over three years, Ecovelex represents a new entrant into the seed treatment market and is intended to replace conventional chemicals banned in the EU and UK. It was developed to tackle crop destruction caused by birds - a major cause of losses in maize and other crops.

 

Ecovelex works by affecting the bird's olfactory system, creating an unpleasant taste or odour that repels the birds, leaving the seeds safely intact and the birds unaffected and free to find alternative food sources.

 

The product is based on plant-derived chemistry and formulated using Eden's Sustaine® microencapsulation system, supporting farmers as they strive to meet consumer demands for more sustainable agriculture.

 

André Negreiros, EMEA Seed Applied Technologies Lead at Corteva Agriscience, said: "After several years of focused and productive collaboration, we are pleased to be reaching the commercialization of Ecovelex. Every year, farmers face heavy losses caused by birds, and recent regulatory changes have meant that the conventional approaches to combating crop damage are no longer available.

 

"The solution we have developed with Eden offers farmers an effective and safe alternative whilst representing a huge step forward in sustainability by using plant chemistry. Eden's team has done an excellent job of helping us tackle this tremendous market opportunity, and we look forward to expanding upon this work in the future."

 

Sean Smith, Eden CEO, said: "Eden's collaboration with Corteva Agriscience over the past several years has been highly productive, and I am pleased to see the first real commercial benefits from these activities within reach. 

 

"Together, we are bringing another safe and effective seed treatment to market in near record time through efficient, open collaboration and a real 'win-win' approach. We will enjoy the rewards of this successful collaboration jointly, but it is the farmers who will also win as we will be providing them with a new tool for improving crop yields, safely and sustainably."

 

Eden has submitted the dossier and application to Austria, who will act as the interzonal rapporteur member state on behalf of the EU. Review and authorization can take between 18 and 24 months, with each EU member state then able to ratify the authorization or require additional information before granting local authorizations.

 

In addition to their work on Ecovelex, Corteva Agriscience and Eden have been engaged in widespread collaborations including on the appointment of Corteva as Eden's distribution partner in France for Eden's fungicide product, Mevalone®. 

 

 

For further information contact:

 

Eden Research plc

Sean SmithAlex Abrey

 

www.edenresearch.com

+44 (0) 1285 359 555

 

 

Cenkos Securities plc (NOMAD and broker to Eden Research plc)

Giles Balleny / Max Gould (corporate finance)Michael Johnson (sales)

 

+44 (0) 20 7397 8900

Hawthorn Advisors (Financial PR to Eden Research plc)

Simon Woods

Felix Meston

eden@hawthornadvisors.com

 

Corteva Media Enquiries

József Máté, Corporate Communications Leader, EMEA

 

jozsef.mate@corteva.com+41 22 775 36 70

+41 79 597 2709

 

Notes to Editors:

 

About Eden

 

Eden is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Eden's products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides. Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN. It was awarded the London Stock Exchange Green Economy Mark in January 2021, which recognises London-listed companies that derive over 50% of their total annual revenue from products and services that contribute to the global green economy. Eden derives 100% of its total annual revenues from sustainable products and services.

 

For more information, please visit: www.edenresearch.com.

 

Follow Eden on LinkedInTwitter and YouTube

 

 

About Corteva 

 

Corteva, Inc. (NYSE: CTVA) is a publicly traded, global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfils its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com. 

 

Follow Corteva on FacebookInstagramLinkedInTwitter and YouTube. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAPGCGDULUDDGXI
Date   Source Headline
29th Jun 202212:18 pmRNSResult of AGM
29th Jun 20227:00 amRNSAGM Statement
8th Jun 20227:12 amRNSNotice of AGM & Publication of Annual Report
7th Jun 20227:00 amRNSInvestor Meet Company: 2021 Results Presentation
31st May 202210:29 amRNSDirector/PDMR Shareholding
31st May 20227:00 amRNSPreliminary results
16th May 20225:05 pmRNSHolding(s) in Company
10th May 20227:00 amRNSRegulatory update
2nd Mar 20227:00 amRNSTrading Update
2nd Dec 20217:00 amRNSNew Major Crop Use for Mevalone in France
20th Oct 20217:00 amRNSAdmission to the US OTC Market
28th Sep 20217:00 amRNSHalf Yearly Report
24th Sep 202112:32 pmRNSNotice of General Meeting
1st Sep 20217:00 amRNSIssuing of Annual Report & Notice of GM
26th Aug 20217:00 amRNSNew label extension for biofungicide in Portugal
28th Jul 20212:53 pmRNSDirector/PDMR Shareholding
27th Jul 20217:00 amRNSAgreement with Sipcam in North Africa
23rd Jul 20217:00 amRNSGrant of Awards under Long-Term Incentive Plan
12th Jul 20214:10 pmRNSHolding(s) in Company
5th Jul 20217:00 amRNSRegulatory approvals
1st Jul 202112:19 pmRNSPublication of Report and Accounts
30th Jun 202112:03 pmRNSResult of AGM
30th Jun 20217:00 amRNSPreliminary Results for Year Ended 31 Dec 2020
29th Jun 202111:27 amRNSVirtual Investor Conference – Link for webinar
7th Jun 20213:28 pmRNSNotice of AGM, investor conference & Accounts
12th May 20217:00 amRNSMilestone Agreement signed with Corteva
10th May 20217:00 amRNSRegulatory approval for Cedroz™ in Italy
1st Apr 20217:00 amRNSGrant of Awards under Long-Term Incentive Plan
31st Mar 20217:00 amRNSNew authorisations for bio-fungicide in Spain
29th Mar 20211:27 pmRNSHolding(s) in Company
19th Feb 20214:41 pmRNSSecond Price Monitoring Extn
19th Feb 20214:35 pmRNSPrice Monitoring Extension
19th Feb 20212:05 pmRNSSecond Price Monitoring Extn
19th Feb 20212:01 pmRNSPrice Monitoring Extension
11th Feb 20219:05 amRNSSecond Price Monitoring Extn
11th Feb 20219:00 amRNSPrice Monitoring Extension
11th Feb 20217:00 amRNSYear end trading update
5th Jan 20217:00 amRNSGreen Economy Mark
2nd Nov 20207:00 amRNSEden partners with M H Poskitt
13th Oct 20207:00 amRNSChange of Registered Office
29th Sep 20207:00 amRNSHalf-year Report
17th Sep 20207:00 amRNSNew authorisations for Cedroz™ and Mevalone®
15th Sep 20207:00 amRNSKey patent granted for Eden’s Sustaine technology
1st Sep 20207:00 amRNSRegulatory approval for Cedroz™ in Spain
25th Aug 20207:00 amRNSNew authorisation for bio-fungicide in Australia
5th Aug 20207:00 amRNSNew authorisation for Cedroz™ in Greece
10th Jul 20207:00 amRNSAppointment of Global Head of Biology and Dev
1st Jul 20207:00 amRNSNew office and laboratory in Oxfordshire
25th Jun 20207:00 amRNSPatents granted in the United States
24th Jun 202012:20 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.